Gainers
- Vaxart VXRT shares increased by 12.27% to $7.96 during Thursday's after-market session. This security traded at a volume of 1.0 million shares come close, making up 15.6% of its average volume over the last 100 days. The market value of their outstanding shares is at $997.1 million.
- Quidel QDEL shares moved upwards by 8.83% to $148.25. At the close, Quidel's trading volume reached 94.2K shares. This is 14.87% of its average volume over the last 100 days. The company's market cap stands at $6.1 billion.
- Precipio PRPO shares moved upwards by 6.17% to $2.75. The company's market cap stands at $62.4 million.
- Avalon Globocare AVCO shares increased by 4.53% to $0.96. The market value of their outstanding shares is at $81.9 million.
- Idera Pharmaceuticals IDRA shares moved upwards by 3.72% to $1.03. The company's market cap stands at $54.3 million.
- Co-Diagnostics CODX stock rose 2.92% to $8.8. The market value of their outstanding shares is at $254.2 million.
Losers
- Agile Therapeutics AGRX stock fell 22.48% to $0.73 during Thursday's after-market session. This security traded at a volume of 493.1K shares come close, making up 74.97% of its average volume over the last 100 days. The company's market cap stands at $67.9 million.
- Cidara Therapeutics CDTX shares fell 10.17% to $1.68. Trading volume for this security closed at 83.8K, accounting for 24.98% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $83.1 million.
- Cellectis CLLS shares fell 4.33% to $11.5. The market value of their outstanding shares is at $522.8 million.
- Erytech Pharma ERYP shares fell 4.16% to $6.0. The company's market cap stands at $166.3 million.
- WAVE Life Sciences WVE shares decreased by 3.81% to $4.55. The company's market cap stands at $231.0 million.
- Medigus MDGS stock fell 2.74% to $1.42. The company's market cap stands at $33.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in